Skip to content

Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review

Research output: Contribution to journalReview article

  • Márcio G. Kiuchi
  • Murray D. Esler
  • Gregory D. Fink
  • John W. Osborn
  • Christopher T. Banek
  • Michael Böhm
  • Kate M. Denton
  • Gerald F. DiBona
  • Thomas H. Everett
  • Guido Grassi
  • Richard E. Katholi
  • Mark M. Knuepfer
  • Ulla C. Kopp
  • David J. Lefer
  • Thomas E. Lohmeier
  • Clive N. May
  • Felix Mahfoud
  • Julian F.R. Paton
  • Roland E. Schmieder
  • Peter R. Pellegrino
  • Yehonatan Sharabi
  • Markus P. Schlaich
Original languageEnglish
Pages (from-to)3006-3017
Number of pages27
JournalJournal of the American College of Cardiology
Volume73
Issue number23
Early online date10 Jun 2019
DOIs
DateAccepted/In press - 15 Apr 2019
DateE-pub ahead of print - 10 Jun 2019
DatePublished (current) - 18 Jun 2019

Abstract

Three recent renal denervation studies in both drug-naïve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.

    Research areas

  • blood pressure, cardiovascular disease, hypertension, renal denervation, sympathetic nervous system

Documents

Documents

  • Full-text PDF (accepted author manuscript)

    Rights statement: This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at http://www.onlinejacc.org/content/73/23/3006 . Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 791 KB, PDF document

    Embargo ends: 18/06/20

    Request copy

    Licence: CC BY-NC-ND

DOI

View research connections

Related faculties, schools or groups